Moscow, Russia

Ellina G Pershina

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ellina G Pershina. Retrieved from https://idiyas.com/inventor/ellina-g-pershina

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 26.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:

goldMedal1 out of 834,601 
Other
 patents

Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Path of Ellina G Pershina

Ellina G Pershina, a talented inventor based in Moscow, Russia, has made significant contributions to the field of antiviral research. With a focus on medical innovations, she holds a notable patent that highlights her commitment to enhancing healthcare.

Latest Patents

Ellina is the sole inventor of a patent for an indole derivative that exhibits antiviral and interferon-inducing properties. This innovative compound has potential applications in treating viral infections, showcasing her dedication to finding solutions in medical science.

Career Highlights

Throughout her career, Ellina has demonstrated her expertise and passion for innovation. Her work in the field of antiviral research has led to the development of cutting-edge solutions aimed at improving patient outcomes. With only one patent to her name, Ellina has already made a significant impact in her area of expertise.

Collaborations

Ellina has collaborated with notable colleagues, including Fedor A Trofimov and Nina G Tsyshkova. These partnerships have likely contributed to her growth as an inventor and the success of her patented research.

Conclusion

In conclusion, Ellina G Pershina represents the spirit of innovation in the scientific community. Her patent for an indole derivative underscores her role as a pioneering inventor in the realm of antiviral treatments. As she continues to push the boundaries of research and development, the potential for her future contributions remains vast.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…